Growth Metrics

Nephros (NEPH) Gross Profit (2016 - 2025)

Nephros has reported Gross Profit over the past 16 years, most recently at $2.8 million for Q4 2025.

  • Quarterly results put Gross Profit at $2.8 million for Q4 2025, up 11.56% from a year ago — trailing twelve months through Dec 2025 was $11.6 million (up 33.27% YoY), and the annual figure for FY2025 was $11.6 million, up 33.27%.
  • Gross Profit for Q4 2025 was $2.8 million at Nephros, down from $2.9 million in the prior quarter.
  • Over the last five years, Gross Profit for NEPH hit a ceiling of $3.2 million in Q1 2025 and a floor of $762000.0 in Q3 2022.
  • Median Gross Profit over the past 5 years was $2.0 million (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Gross Profit: plummeted 43.97% in 2022 and later soared 187.93% in 2023.
  • Nephros' Gross Profit stood at $1.5 million in 2021, then grew by 2.58% to $1.5 million in 2022, then skyrocketed by 33.93% to $2.0 million in 2023, then rose by 22.46% to $2.5 million in 2024, then increased by 11.56% to $2.8 million in 2025.
  • The last three reported values for Gross Profit were $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $2.8 million (Q2 2025) per Business Quant data.